Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Monday, November 2, 2026

Back to today

BMRN Earnings Review

BioMarin’s Q3 revenue rose 32% to $1.02 billion after the Amicus acquisition, while lower 2026 guidance and $2.8 billion of net debt weighed on earnings.

BMRN $11B
Cestrian Capital Research 1 click

From X

@AsifSuria

Asif Suria on X

Yesterday we recorded a podcast covering two potential deal situations including rumors of Marvell $MRVL acquiring Lumentum $LITE. The deal was confirmed a few minutes before the podcast was uploaded to YouTube this morning. As a Marvell shareholder I was not particularly happy about this deal as I discussed in the podcast and the price action late last week and this morning confirms the market feels the same way. You can check out the podcast on Spotify, Apple Podcasts and YouTube here: https://t.co/DgbNJ12OYo
@convequity 1 click

Convequity on X

Burn-in testing puts chips through demanding conditions to help identify devices likely to fail early in use. Aehr Test Systems ($AEHR) supplies wafer-level burn-in systems. Cohu ($COHU) supplies equipment for other semiconductor tests. This testing becomes more valuable as manufacturers combine more chips into expensive packages and systems. One weak component can cause problems for an assembly worth far more than the chip itself. Finding that weakness before the equipment reaches a customer can therefore justify spending more on testing, because the failure can affect the larger assembly.
@aleabitoreddit 1 click

Serenity on X

$LITE standalone would likely be up on earnings after their new $5B CPO/NPO announcement (separate from $NVDA). The margins on that are likely 60%+… which shows how profitable laser players would be at scale. (Greensboro alone would be $5B revenue/year) In terms of the $MRVL deal: - Extremely positive for Marvell strategically. Also makes remaining laser players very valuable - $LITE shareholders can cry though about the 1+ year overhang until deal goes through in 2028. There’s less independent price discovery as well since a lot of it will be pegged around 4.5 Marvell shares : 1 - I think Lumentum shareholders probably would be happier if Marvell shares didn’t crash before the deal was announced.. since it was originally valuing $LITE at $115B with a 23.9% premium. - Marvell dropping does show the downside of the deal straight away though, if it rose then $LITE shareholders might be a tad happier given valuation. Having a fixed dollar MC value floor probably would have been better than the 4.5x:1 ratio. There was a lot of long $LITE, short ___ pressuring other photonics valuations, so at least those trade pairs might unwind now

Investor Letters

All letters

Altria: Dutiful

Altria raised 2026 adjusted EPS guidance to $5.66 to $5.74 and authorized more buybacks, while on! loses share as cigarette margins hold.

MO $130B
Invariant 2 clicks
PRIM · long

Primoris Services CORP

Primoris Services, a $5 billion EPC contractor, has fallen about 60% from its peak.

PRIM $3.9B
Value Investors Club

When the liquidity does not add up

Arbor Realty Trust’s dividend suspension is presented as creating $60 million of liquidity, raising questions about its ability to meet…

ABR $2.2B
John Hempton's Newsletter 3 clicks

FTAI 3Q26: Aero margins in focus

FTAI’s Aerospace Products margin rebounded to 31% as CFM56 module output rose, while Power deposits and contracted deliveries fund its 2027…

FTAI $20B
Stock Thoughts 4 clicks

CVX Earnings Review

Chevron’s Q3 revenue rose 35% to $65.2 billion and EBITDA 75% to $20.2 billion, while production trailed guidance and refining margins…

CVX $423B
Cestrian Capital Research 3 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 70 of 272

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

266 firms

Sectors

Ordered by how often our editor reaches for them.